We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+1.02%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.06B
AUM Growth
-$1.38M
Cap. Flow
+$20.5M
Cap. Flow %
1.94%
Top 10 Hldgs %
7.1%
Holding
774
New
159
Increased
222
Reduced
220
Closed
120

Top Buys

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$5.67M
2
SOFI icon
SoFi Technologies
SOFI
+$5.22M
3
TRU icon
TransUnion
TRU
+$4.01M
4
EXPE icon
Expedia Group
EXPE
+$3.93M
5
CNMD icon
CONMED
CNMD
+$3.78M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$7.81M
2
SWK icon
Stanley Black & Decker
SWK
+$5.62M
3
KMX icon
CarMax
KMX
+$4.41M
4
SG icon
Sweetgreen
SG
+$4.23M
5
MU icon
Micron Technology
MU
+$4.08M

Sector Composition

Rank Sector Weight
1 Technology 20.53%
2 Healthcare 19.51%
3 Industrials 14.23%
4 Consumer Discretionary 11.24%
5 Financials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RL icon
76
Ralph Lauren
RL
$22.2B
$3.6M 0.34%
20,572
+6
+0% +$1.04K
AROC icon
77
Archrock
AROC
$6.33B
$3.6M 0.34%
177,848
-464
-0.3% -$9.2K
BWLP icon
78
BW LPG
BWLP
$3.31B
$3.59M 0.34%
+193,308
New +$3.42M
CAMT icon
79
Camtek
CAMT
$6.9B
$3.58M 0.34%
28,610
+1,809
+7% +$173K
APLS
80
DELISTED
Apellis Pharmaceuticals
APLS
$3.56M 0.34%
92,856
+36,335
+64% +$1.65M
BROS icon
81
Dutch Bros
BROS
$8.78B
$3.54M 0.34%
85,533
-44
-0.1% -$1.51K
FRSH icon
82
Freshworks
FRSH
$2.84B
$3.53M 0.33%
278,332
+48,371
+21% +$724K
NTNX icon
83
Nutanix
NTNX
$14.9B
$3.5M 0.33%
61,514
+2,599
+4% +$160K
CLS icon
84
Celestica
CLS
$35.1B
$3.48M 0.33%
60,728
+30,328
+100% +$1.53M
ZS icon
85
Zscaler
ZS
$23B
$3.48M 0.33%
18,103
+304
+2% +$54.1K
ALNY icon
86
Alnylam Pharmaceuticals
ALNY
$36.3B
$3.47M 0.33%
+14,284
New +$2.26M
MHK icon
87
Mohawk Industries
MHK
$6.9B
$3.41M 0.32%
29,993
-5,803
-16% -$675K
WRBY icon
88
Warby Parker
WRBY
$3.01B
$3.38M 0.32%
210,421
+26,153
+14% +$387K
CVLT icon
89
Commault Systems
CVLT
$5.89B
$3.38M 0.32%
27,777
+17,169
+162% +$1.84M
TRMD icon
90
TORM
TRMD
$3.1B
$3.35M 0.32%
86,403
+54,690
+172% +$1.96M
FROG icon
91
JFrog
FROG
$9.71B
$3.31M 0.31%
88,176
NVDA icon
92
NVIDIA
NVDA
$5.01T
$3.31M 0.31%
26,788
-1,212
-4% -$123K
AKRO
93
DELISTED
Akero Therapeutics
AKRO
$3.27M 0.31%
139,296
+14,848
+12% +$318K
AJG icon
94
Arthur J. Gallagher & Co
AJG
$63.7B
$3.26M 0.31%
12,565
+14
+0.1% +$3.47K
AGIO icon
95
Agios Pharmaceuticals
AGIO
$2.16B
$3.25M 0.31%
75,280
-18,124
-19% -$654K
NVCR icon
96
NovoCure
NVCR
$2.04B
$3.23M 0.31%
188,422
+100
+0.1% +$1.76K
SM icon
97
SM Energy
SM
$7.96B
$3.23M 0.31%
74,628
SONO icon
98
Sonos
SONO
$1.75B
$3.17M 0.3%
214,850
-18,074
-8% -$300K
REGN icon
99
Regeneron Pharmaceuticals
REGN
$68.8B
$3.15M 0.3%
+3,000
New +$2.91M
CALX icon
100
Calix
CALX
$2.27B
$3.15M 0.3%
88,791
+14,261
+19% +$459K

Similar funds

PDT Partners's Q2 2024 Portfolio in Review

As of Q2 2024, PDT Partners held 774 positions worth $1.06B, down 0.13% from $1.06B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

PDT Partners's Q2 2024 filing shows 159 new, 222 increased, 220 reduced and 120 closed positions. Its largest new stake was SoFi Technologies: 740,850 shares worth $4.9M. The largest sale was Ferrari, an estimated $7.81M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • PDT Partners's largest Q2 2024 buy was SoFi Technologies: 740,850 shares worth $4.9M.
  • PDT Partners added most to 10x Genomics in Q2 2024, an estimated $5.67M increase.
  • PDT Partners's biggest Q2 2024 reduction was Ferrari, cutting an estimated $7.81M.
  • PDT Partners fully exited CarMax in Q2 2024, selling an estimated $4.41M.
  • PDT Partners's ten largest holdings make up 7.1% of its $1.06B portfolio in Q2 2024.
  • PDT Partners opened 159 new positions and closed 120 in Q2 2024.
  • PDT Partners's portfolio value fell 0.13% quarter-over-quarter to $1.06B.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.